Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Jan 19, 2021 8:26pm
150 Views
Post# 32330471

RE:Max Complaining = Main Pain. Keep it up Fellas

RE:Max Complaining = Main Pain. Keep it up FellasSorry - shareholders are not the ones deserving blame for the current debacle related to this financing. No amount of blame shifting you might engage in will work because it really does not make any sense. The stock price has been crushed because the company leadership made a huge error with this financing. I don't expect the share price to remain crushed but I certainly understand why it is crushed at the moment and that is certainly not because shareholders are pointing out the obvious. If we had all gagged ourselves in our basements until we made it through all the stages of grief, the stock still would have been crushed because the financing was a freaking disaster. We talk among ourselves on this board but it is a relatively small number of people who do not have a meaningful impact on the stock. 

realitycheck4u wrote: Congrats.  The people here (most of you) have held shares the longest and are the biggest whiners. Go figure. So your potential windfall for the past 8 years is now been chopped by 20%. Big deal. You are under water and they needed to reduce the risk - and yes they could have increased marketing beforehand - but they didn't. Get over it. Your complaints have been heard. So, keep it up. Keep complaining of the very same thing over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over and over.

Eventually you will succeed is just giving up and selling as you will be the actually reason why this stock moves slow.  It's because of the risk of terrible shareholders...not the company.  So sell.  And I will welcome a whole new crew of excited shareholders without all of your baggage.




<< Previous
Bullboard Posts
Next >>